129 related articles for article (PubMed ID: 38051197)
1. Adjuvant Topical Sirolimus for Pulsed Dye Laser in Pediatric Capillary Malformation.
Gu Y; Sebaratnam DF
Dermatol Surg; 2024 Mar; 50(3):300-301. PubMed ID: 38051197
[No Abstract] [Full Text] [Related]
2. Topical rapamycin and microcystic lymphatic malformations.
Gu Y; Sebaratnam DF
J Am Acad Dermatol; 2024 Jan; 90(1):e29-e30. PubMed ID: 37717734
[No Abstract] [Full Text] [Related]
3. Evaluating the efficacy and safety of topical sirolimus 0.2% cream as adjuvant therapy with pulsed dye laser for the treatment of port wine stain: A randomized, double-blind, placebo-controlled trial.
Fallahi M; Hallaji Z; Tavakolpour S; Niknam S; Salehi Farid A; Nili A; Teimourpour A; Daneshpazhooh M; Rahmati J; Haddady Abianeh S; Mahmoudi H
J Cosmet Dermatol; 2021 Aug; 20(8):2498-2506. PubMed ID: 33251650
[TBL] [Abstract][Full Text] [Related]
4. Port wine stain treated with a combination of pulsed dye laser and topical rapamycin ointment.
Griffin TD; Foshee JP; Finney R; Saedi N
Lasers Surg Med; 2016 Feb; 48(2):193-6. PubMed ID: 26503090
[TBL] [Abstract][Full Text] [Related]
5. RF-Topical Rapamycin as an Adjuvant to Laser Treatment in Capillary Malformations.
Alegre-Sánchez A; Boixeda P
Actas Dermosifiliogr (Engl Ed); 2018 Dec; 109(10):915-916. PubMed ID: 29636196
[No Abstract] [Full Text] [Related]
6. Prospective pilot study on combined use of pulsed dye laser and 1% topical rapamycin for treatment of nonfacial cutaneous capillary malformation.
Doh EJ; Ohn J; Kim MJ; Kim YG; Cho S
J Dermatolog Treat; 2017 Nov; 28(7):672-677. PubMed ID: 28285560
[TBL] [Abstract][Full Text] [Related]
7. Treatment of port wine stains using Pulsed Dye Laser, Erbium YAG Laser, and topical rapamycin (sirolimus)-A randomized controlled trial.
Greveling K; Prens EP; van Doorn MB
Lasers Surg Med; 2017 Jan; 49(1):104-109. PubMed ID: 27320685
[TBL] [Abstract][Full Text] [Related]
8. Good response to pulsed dye laser in patients with capillary malformation-arteriovenous malformation syndrome (CM-AVM).
Iznardo H; Roé E; Puig L; Vikula M; López-Sánchez C; Baselga E
Pediatr Dermatol; 2020 Mar; 37(2):342-344. PubMed ID: 31944370
[TBL] [Abstract][Full Text] [Related]
9. Topical rapamycin combined with pulsed dye laser in the treatment of capillary vascular malformations in Sturge-Weber syndrome: phase II, randomized, double-blind, intraindividual placebo-controlled clinical trial.
Marqués L; Núñez-Córdoba JM; Aguado L; Pretel M; Boixeda P; Nagore E; Baselga E; Redondo P
J Am Acad Dermatol; 2015 Jan; 72(1):151-8.e1. PubMed ID: 25455610
[TBL] [Abstract][Full Text] [Related]
10. Outcome with topical sirolimus for port wine stain malformations after unsatisfactory results with pulse dye laser treatment alone.
Musalem HM; Alshaikh AA; Tuleimat LM; Alajlan S
Ann Saudi Med; 2018; 38(5):376-380. PubMed ID: 30284993
[TBL] [Abstract][Full Text] [Related]
11. Topical Adjuncts to Pulsed Dye Laser for Treatment of Port Wine Stains: Review of the Literature.
Lipner SR
Dermatol Surg; 2018 Jun; 44(6):796-802. PubMed ID: 29799824
[TBL] [Abstract][Full Text] [Related]
12. Topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations-Anatomical differences in response to PDL are relevant to interpretation of study results.
Bloom BS; Nelson JS; Geronemus RG
J Am Acad Dermatol; 2015 Aug; 73(2):e71. PubMed ID: 26184004
[No Abstract] [Full Text] [Related]
13. Reply to: "Topical rapamycin combined with pulsed dye laser (PDL) in the treatment of capillary vascular malformations-Anatomical differences in response to PDL are relevant to interpretation of study results".
Marqués L; Núñez-Córdoba JM; Aguado L; Pretel M; Boixeda P; Nagore E; Baselga E; Redondo P
J Am Acad Dermatol; 2015 Aug; 73(2):e73-4. PubMed ID: 26184005
[No Abstract] [Full Text] [Related]
14. Targeted topical and combination laser surgery for the treatment of angiofibromas.
Bae-Harboe YS; Geronemus RG
Lasers Surg Med; 2013 Nov; 45(9):555-7. PubMed ID: 24136238
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive in vivo assessment of vessel characteristics in capillary vascular malformations exposed to five pulsed dye laser treatments.
Sivarajan V; Mackay IR
Plast Reconstr Surg; 2005 Apr; 115(5):1245-52. PubMed ID: 15809581
[TBL] [Abstract][Full Text] [Related]
16. Topical rapamycin systematically suppresses the early stages of pulsed dye laser-induced angiogenesis pathways.
Gao L; Phan S; Nadora DM; Chernova M; Sun V; Preciado SM; Ballew B; Jia Z; Jia W; Wang G; Mihm MC; Nelson JS; Tan W
Lasers Surg Med; 2014 Nov; 46(9):679-88. PubMed ID: 25270513
[TBL] [Abstract][Full Text] [Related]
17. Treatment of capillary malformation using topical timolol combined with 585-nm pulsed dye laser: a prospective, randomized, split-lesion study.
Cheon SJ; Shim WH; Kim GW; Kim HS; Kim BS; Kim MB; Ko HC
J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):e328-e329. PubMed ID: 28079942
[No Abstract] [Full Text] [Related]
18. Treatment of capillary malformations in capillary malformation-arteriovenous malformation syndrome with pulsed dye laser.
Ang YS; Koh MJA
J Cosmet Dermatol; 2021 Nov; 20(11):3710-3711. PubMed ID: 33655684
[No Abstract] [Full Text] [Related]
19. Capillary Malformations Treated With Sequential Pulsed Dye and Nd:YAG Laser Therapy: A Retrospective Study.
Alcántara-González J; Boixeda P; Truchuelo-Díez MT; Jiménez-Gómez N; Pérez-García B; Pérez-Carmona L; Jaén Olasolo P
Actas Dermosifiliogr (Engl Ed); 2018 Mar; 109(2):155-161. PubMed ID: 29183621
[TBL] [Abstract][Full Text] [Related]
20. Preventive treatment with oral sirolimus and aspirin in a newborn with severe Sturge-Weber syndrome.
Triana Junco PE; Sánchez-Carpintero I; López-Gutiérrez JC
Pediatr Dermatol; 2019 Jul; 36(4):524-527. PubMed ID: 31134637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
